Poniard Pharmaceuticals (PARD) 10-Q 2011 Q2 Quarterly report

Exhibit 32.2

CERTIFICATION OF QUARTERLY REPORT

I, Michael K. Jackson, Interim Chief Financial Officer of Poniard Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350, that:

a. the Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

b. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 12, 2011	By:	/s/ MICHAEL K. JACKSON
		Michael K. Jackson
		Interim Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)